Center for the Evaluation of Biomarkers for Early Detection of Breast Cancer
Abstract
Breast Cancer remains a leading cause of death for women in the US despite the popularity of mammography as a preventive tool. At diagnosis, many breast cancers are at an advanced stage of disease, even for women undergoing annual screening, resulting in costly and painful follow-up procedures. It has been shown that molecular markers can increase our ability to diagnose early stages tumors. This has been demonstrated by current clinical practices using the CA-125 marker and PSA for the detection of ovarian and prostate cancer, respectively. The purpose of this study is to search for breast cancer biomarkers and evaluate their effectiveness in detecting early stage carcinoma. By combining molecular diagnosis with current imaging analysis of breast tissue, we may further reduce the number of deaths as well as the number of women undergoing surgery due to breast cancer. To date, we have created the infrastructure necessary for our interdisciplinary team of investigators to obtain study samples from a well-characterized population, analyze candidate biomarkers, and efficiently communicate research findings. We are also exploring more efficient and sensitive biotechnology that may better assist our study investigators.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2006
- Accession Number
- ADA460759
Entities
People
- Nicole Urban
Organizations
- Fred Hutchinson Cancer Center